Sign In

Login

Password

Forgot Password ? Sign Up

Brequinar (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Brequinar" in German language version.

refsWebsite
Global rank German rank
12nih.gov
4th place
7th place
10doi.org
2nd place
3rd place
1sigmaaldrich.com
924th place
87th place

doi.org

  • G. J. Peters: Re-evaluation of Brequinar sodium, a dihydroorotate dehydrogenase inhibitor. In: Nucleosides, nucleotides & nucleic acids. Band 37, Nummer 12, 2018, S. 666–678, doi:10.1080/15257770.2018.1508692 (freier Volltext), PMID 30663496.
  • M. Lucas-Hourani, D. Dauzonne, P. Jorda, G. Cousin, A. Lupan, O. Helynck, G. Caignard, G. Janvier, G. André-Leroux, S. Khiar, N. Escriou, P. Desprès, Y. Jacob, H. Munier-Lehmann, F. Tangy, P. O. Vidalain: Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity. In: PLoS pathogens. Band 9, Nummer 10, 2013, S. e1003678, doi:10.1371/journal.ppat.1003678, PMID 24098125, PMC 3789760 (freier Volltext).
  • D. V. Cramer: Brequinar sodium. In: Pediatric nephrology. Band 9 Suppl, 1995, S. S52–S55, doi:10.1007/bf00867685, PMID 7492488.
  • V. K. Vyas, M. Ghate: Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors. In: Mini reviews in medicinal chemistry. Band 11, Nummer 12, Oktober 2011, S. 1039–1055, doi:10.2174/138955711797247707, PMID 21861807.
  • J. T. Madak, A. Bankhead, C. R. Cuthbertson, H. D. Showalter, N. Neamati: Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer. In: Pharmacology & therapeutics. Band 195, 03 2019, S. 111–131, doi:10.1016/j.pharmthera.2018.10.012, PMID 30347213.
  • D. Boschi, A. C. Pippione, S. Sainas, M. L. Lolli: Dihydroorotate dehydrogenase inhibitors in anti-infective drug research. In: European journal of medicinal chemistry. Band 183, Dezember 2019, S. 111681, doi:10.1016/j.ejmech.2019.111681, PMID 31557612.
  • S. F. Li, M. J. Gong, Y. F. Sun, J. J. Shao, Y. G. Zhang, H. Y. Chang: Antiviral activity of brequinar against foot-and-mouth disease virus infection in vitro and in vivo. In: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. Band 116, August 2019, S. 108982, doi:10.1016/j.biopha.2019.108982, PMID 31146110.
  • P. I. Andersen, K. Krpina, A. Ianevski, N. Shtaida, E. Jo, J. Yang, S. Koit, T. Tenson, V. Hukkanen, M. W. Anthonsen, M. Bjoras, M. Evander, M. P. Windisch, E. Zusinaite, D. E. Kainov: Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine. In: Viruses. Band 11, Nummer 10, Oktober 2019, S. , doi:10.3390/v11100964, PMID 31635418, PMC 6832696 (freier Volltext).
  • J. G. Park, G. Ávila-Pérez, A. Nogales, P. Blanco-Lobo, J. C. de la Torre, L. Martínez-Sobrido: Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses. In: Journal of Virology. Band 94, Nummer 7, März 2020, S. , doi:10.1128/JVI.02149-19, PMID 31941776, PMC 7081893 (freier Volltext).
  • S. F. Li, M. J. Gong, Y. F. Sun, J. J. Shao, Y. G. Zhang, H. Y. Chang: Antiviral activity of brequinar against foot-and-mouth disease virus infection in vitro and in vivo. In: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Band 116, August 2019, S. 108982; doi:10.1016/j.biopha.2019.108982, PMID 31146110.

nih.gov

ncbi.nlm.nih.gov

  • G. J. Peters: Re-evaluation of Brequinar sodium, a dihydroorotate dehydrogenase inhibitor. In: Nucleosides, nucleotides & nucleic acids. Band 37, Nummer 12, 2018, S. 666–678, doi:10.1080/15257770.2018.1508692 (freier Volltext), PMID 30663496.
  • M. Lucas-Hourani, D. Dauzonne, P. Jorda, G. Cousin, A. Lupan, O. Helynck, G. Caignard, G. Janvier, G. André-Leroux, S. Khiar, N. Escriou, P. Desprès, Y. Jacob, H. Munier-Lehmann, F. Tangy, P. O. Vidalain: Inhibition of pyrimidine biosynthesis pathway suppresses viral growth through innate immunity. In: PLoS pathogens. Band 9, Nummer 10, 2013, S. e1003678, doi:10.1371/journal.ppat.1003678, PMID 24098125, PMC 3789760 (freier Volltext).
  • D. V. Cramer: Brequinar sodium. In: Pediatric nephrology. Band 9 Suppl, 1995, S. S52–S55, doi:10.1007/bf00867685, PMID 7492488.
  • X. Xu, J. W. Williams, J. Shen, H. Gong, D. P. Yin, L. Blinder, R. T. Elder, H. Sankary, A. Finnegan, A. S. Chong: In vitro and in vivo mechanisms of action of the antiproliferative and immunosuppressive agent, brequinar sodium. In: Journal of immunology. Band 160, Nummer 2, Januar 1998, S. 846–853, PMID 9551920.
  • V. K. Vyas, M. Ghate: Recent developments in the medicinal chemistry and therapeutic potential of dihydroorotate dehydrogenase (DHODH) inhibitors. In: Mini reviews in medicinal chemistry. Band 11, Nummer 12, Oktober 2011, S. 1039–1055, doi:10.2174/138955711797247707, PMID 21861807.
  • J. T. Madak, A. Bankhead, C. R. Cuthbertson, H. D. Showalter, N. Neamati: Revisiting the role of dihydroorotate dehydrogenase as a therapeutic target for cancer. In: Pharmacology & therapeutics. Band 195, 03 2019, S. 111–131, doi:10.1016/j.pharmthera.2018.10.012, PMID 30347213.
  • D. Boschi, A. C. Pippione, S. Sainas, M. L. Lolli: Dihydroorotate dehydrogenase inhibitors in anti-infective drug research. In: European journal of medicinal chemistry. Band 183, Dezember 2019, S. 111681, doi:10.1016/j.ejmech.2019.111681, PMID 31557612.
  • S. F. Li, M. J. Gong, Y. F. Sun, J. J. Shao, Y. G. Zhang, H. Y. Chang: Antiviral activity of brequinar against foot-and-mouth disease virus infection in vitro and in vivo. In: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie. Band 116, August 2019, S. 108982, doi:10.1016/j.biopha.2019.108982, PMID 31146110.
  • P. I. Andersen, K. Krpina, A. Ianevski, N. Shtaida, E. Jo, J. Yang, S. Koit, T. Tenson, V. Hukkanen, M. W. Anthonsen, M. Bjoras, M. Evander, M. P. Windisch, E. Zusinaite, D. E. Kainov: Novel Antiviral Activities of Obatoclax, Emetine, Niclosamide, Brequinar, and Homoharringtonine. In: Viruses. Band 11, Nummer 10, Oktober 2019, S. , doi:10.3390/v11100964, PMID 31635418, PMC 6832696 (freier Volltext).
  • J. G. Park, G. Ávila-Pérez, A. Nogales, P. Blanco-Lobo, J. C. de la Torre, L. Martínez-Sobrido: Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses. In: Journal of Virology. Band 94, Nummer 7, März 2020, S. , doi:10.1128/JVI.02149-19, PMID 31941776, PMC 7081893 (freier Volltext).
  • S. F. Li, M. J. Gong, Y. F. Sun, J. J. Shao, Y. G. Zhang, H. Y. Chang: Antiviral activity of brequinar against foot-and-mouth disease virus infection in vitro and in vivo. In: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Band 116, August 2019, S. 108982; doi:10.1016/j.biopha.2019.108982, PMID 31146110.
  • S. Dasgupta, DM. Timby, GN. Lam: Determination of brequinar in rat plasma by direct deproteinization and reversed-phase high-performance liquid chromatography with ultraviolet absorbance detection. In: J Chromatogr B Biomed Appl., 1995 Nov 3, 673(1), S. 107–112; PMID 8925063

sigmaaldrich.com